Cite

HARVARD Citation

    KINJO, M. et al. (2018). Long‐term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial. LUTS. 10 (2), pp. 148-152. [Online]. 
  
Back to record